Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1155520080030040250
Anesthesia and Pain Medicine
2008 Volume.3 No. 4 p.250 ~ p.254
The effect of methods of ondansetron administration on nausea and vomiting during intravenous patient-controlled analgesia in pediatric patients undergoing pectus excavatum repair
Shin Youn-Sik

Kim Yoon-Young
Lee Yoon-Sook
Kim Jae-Hwan
Park Young-Cheol
Chang Moon-Seok
Baek Sung-Moon
Abstract
Background: Postoperative nausea and vomiting remain troublesome problems, especially in pediatric patients receiving the opioid analgesics. This study was designed to evaluate the difference between bolus injection and continuous infusion of ondansetron for the prevention of postoperative nausea and vomiting in pediatric patients with intravenous patient-controlled analgesia (IV-PCA).

Methods: Sixty patients undergoing pectus excavatum repair were randomly assigned into three groups, no antiemetic (Group 1, n = 20), intraoperative ondansetron 0.1 mg/kg IV bolus (Group 2, n = 20), ondansetron 0.1 mg/kg mixed with IV-PCA (Group 3, n = 20). The incidence of nausea, vomiting, the need for rescue antiemetics, side effects and pain score were recorded for 48 hr postoperatively.

Results: The incidence of nausea in Group 2 (20%) and Group 3 (25%) was significantly lower than Group 1 (60%). There was no significant difference in the incidence of vomiting among the groups (Group 1£º60%, Group 2£º20%, Group 3£º20%). The need for rescue antiemetics was significantly lower in Group 2 and 3 than Group 1.

Conclusions: In pediatric patients undergoing pectus excavatum repair, bolus injection and continuous infusion of ondansetron were effective in preventing postoperative nausea during IV-PCA. And the need for rescue antiemetics was significantly decreased.
KEYWORD
intravenous patient-controlled analgesia, nausea and vomiting, Ondansetron, pectus excavatum
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø